Kilambi News
Sunday, November 22, 2026

Archive

Every story, newest first.

Thursday, October 29, 2026

Politics

UK commits further 10 billion pounds to Ukraine

The United Kingdom will give Ukraine a further 10 billion pounds of economic and military support, its largest ever package for Kyiv, taking total UK commitments to 35 billion pounds.

Politics

Tanzania marks year since election violence without accountability

One year after Tanzania's post-election violence, in which a government appointed commission recorded 518 deaths, no official has been criminally investigated for the security forces' use of force, Amnesty International and Human Rights Watch said this week.

Politics

Senate map widens to Mississippi and Nebraska late

Senate Democrats are spending 500,000 dollars in Mississippi in the final week and Nebraska has become an unexpected battleground on economic pain, widening a map that yesterday's polls already showed tied in South Carolina five days before the November 3 midterms.

Politics

Politics also notable: Zelenskyy, voting charges, impeachment talk

Also notable in politics: President Zelenskyy objected to a US-Russia-China summit, US conservative activists were charged over an unlawful voting stunt, and senior Democrats publicly split over impeaching President Trump or Secretary Hegseth.

Politics

Hegseth proposes US ASEAN defense framework in Cebu

US Defense Secretary Pete Hegseth proposed a US-ASEAN framework for defense cooperation in Cebu on Wednesday, pledging stronger maritime domain awareness, interoperability and naval cooperation as Southeast Asian governments weigh Washington's focus while the Iran war strains US resources.

Life Sciences

DBV submits peanut patch licence application and seeks priority review

DBV Technologies said on October 28 that it has submitted a Biologics License Application to the Food and Drug Administration for its Viaskin peanut patch in children aged 4 to 7 years and requested Priority Review, with $165.7 million of cash funding it into the third quarter of 2027.

Life Sciences

CONMED organic sales grow 6.7 percent after GI product exit

CONMED reported third quarter sales of $335.6 million, down 0.7 percent as reported but up 6.7 percent on an organic constant currency basis excluding its exited gastroenterology lines, with GAAP earnings per share of $0.66, on October 28.

Life Sciences

Community Health Systems posts loss as revenue falls 10.7 percent

Community Health Systems reported third quarter net operating revenues of $2.757 billion, down 10.7 percent, and a net loss attributable to stockholders of $86 million, or $0.63 per share, on October 28, against net income of $130 million a year earlier.

Life Sciences

Butterfly Network revenue grows 52 percent and guidance rises

Butterfly Network reported third quarter revenue of $32.6 million, up 52 percent, with a record gross margin of 73 percent, on October 29, and raised full year 2026 revenue guidance to $123 million to $126 million.

Life Sciences

Astellas options Audax IL-12 cancer drug in $1.34 billion deal

Astellas has taken an exclusive option to license DAX-044, Audax Biosciences' preclinical IL-12 antibody cytokine fusion for solid tumors, with $285 million in upfront and option payments and up to $1.05 billion in milestones, the companies said on October 27.